Published in

Wiley, European Journal of Haematology, 5(82), p. 364-372, 2009

DOI: 10.1111/j.1600-0609.2009.01222.x

Links

Tools

Export citation

Search in Google Scholar

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas

Journal article published in 2008 by Heidi Nyman, Mats Jerkeman, Marja-Liisa Karjalainen-Lindsberg, Alison H. Banham ORCID, Gunilla Enblad, Sirpa Marianne Leppa ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO